Terms: = Germ cell tumor AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Prognosis
31 results:
1. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach.
Kartal B; Denizler-Ebiri FN; Güven M; Taşpınar F; Canpınar H; Çetin S; Karaduman T; Küççüktürk S; Castresana J; Taşpınar M
Med Oncol; 2024 Mar; 41(5):97. PubMed ID: 38532150
[TBL] [Abstract] [Full Text] [Related]
2. Colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.
Ho YH; Hsu CY; Yau Li AF; Liang WY
Hum Pathol; 2024 Mar; 145():80-85. PubMed ID: 38423221
[TBL] [Abstract] [Full Text] [Related]
3. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment.
Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
[TBL] [Abstract] [Full Text] [Related]
4. SOMATIC DEFICIENT MISMATCH REPAIR ASSESSED BY IMMUNOHISTOCHEMISTRY AND CLINICAL FEATURES IN BRAZILIAN GLIOBLASTOMA PATIENTS.
Yamada CAF; Malheiros SMF; Do Amaral LLF; Lancellotti CLP
Exp Oncol; 2023 Dec; 45(3):297-311. PubMed ID: 38186025
[TBL] [Abstract] [Full Text] [Related]
5. IDH-mutant diffuse gliomas: tips and tricks in the era of genomic tumor classification.
Ammendola S; Broggi G; Barresi V
Histol Histopathol; 2023 Jul; 38(7):739-753. PubMed ID: 36651583
[TBL] [Abstract] [Full Text] [Related]
6. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
Li K; Liu Y; Han J; Gui J; Zhang X
Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
[TBL] [Abstract] [Full Text] [Related]
7. Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine Neoplasia: A Report of 14 Cases.
Ordulu Z; Mino-Kenudson M; Young RH; Van de Vijver K; Zannoni GF; Félix A; Burandt E; Wong A; Nardi V; Oliva E
Am J Surg Pathol; 2022 Dec; 46(12):1670-1681. PubMed ID: 36069807
[TBL] [Abstract] [Full Text] [Related]
8. DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and prognosis.
Gisder DM; Overheu O; Keller J; Nöpel-Dünnebacke S; Uhl W; Reinacher-Schick A; Tannapfel A; Tischoff I
Pathobiology; 2023; 90(2):71-80. PubMed ID: 35691289
[TBL] [Abstract] [Full Text] [Related]
9. An integrative pan-cancer analysis reveals the oncogenic role of mutS homolog 6 (msh6) in human tumors.
Zhan H; Mo F; Xu Q; Wang S; Zhang B; Liu X; Dai M; Liu H
Aging (Albany NY); 2021 Dec; 13(23):25271-25290. PubMed ID: 34941572
[TBL] [Abstract] [Full Text] [Related]
10. Mismatch repair proteins PMS2 and MLH1 can further refine molecular stratification of IDH-mutant lower grade astrocytomas.
Yang RR; Li KK; Zhang ZY; Chan AK; Wang WW; Chan DT; Li WC; Liu XZ; Li FC; Chen H; Ng HK; Mao Y; Shi ZF
Clin Neurol Neurosurg; 2021 Sep; 208():106882. PubMed ID: 34428613
[TBL] [Abstract] [Full Text] [Related]
11. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE
Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206
[TBL] [Abstract] [Full Text] [Related]
12.
Shi Y; Jiang J; Cui Y; Chen Y; Dong T; An H; Liu P
DNA Cell Biol; 2021 Jan; 40(1):93-100. PubMed ID: 33181035
[TBL] [Abstract] [Full Text] [Related]
13. Identification of New Genetic Clusters in Glioblastoma Multiforme:
Navarro L; San-Miguel T; Megías J; Santonja N; Calabuig S; Muñoz-Hidalgo L; Roldán P; Cerdá-Nicolás M; López-Ginés C
Cells; 2020 Nov; 9(11):. PubMed ID: 33172155
[TBL] [Abstract] [Full Text] [Related]
14. Homogeneous MMR Deficiency Throughout the Entire tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
Fraune C; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Amin T; Viol F; Fehrle W; Dum D; Höflmayer D; Burandt E; Clauditz TS; Perez D; Izbicki J; Wilczak W; Sauter G; Steurer S; Schrader J
Endocr Pathol; 2020 Jun; 31(2):182-189. PubMed ID: 32144630
[TBL] [Abstract] [Full Text] [Related]
15. Quantitative Proteomics Analysis Reveals Nuclear Perturbation in Human Glioma U87 cells treated with Temozolomide.
Guo J; Yi GZ; Liu Z; Sun X; Yang R; Guo M; Li Y; Li K; Li K; Wang X; Song H; Qi S; Huang G; Liu Y
Cell Biochem Funct; 2020 Mar; 38(2):185-194. PubMed ID: 31833081
[TBL] [Abstract] [Full Text] [Related]
16. Lynch syndrome-associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome.
Yang C; Austin F; Richard H; Idowu M; Williamson V; Sabato F; Ferreira-Gonzalez A; Turner SA
Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31604779
[TBL] [Abstract] [Full Text] [Related]
17. Microsatellite Instability in Glioblastoma: Is It Really Relevant in tumor prognosis?
Tepeoglu M; Borcek P; Ozen O; Altinors N
Turk Neurosurg; 2019; 29(5):778-784. PubMed ID: 31529454
[TBL] [Abstract] [Full Text] [Related]
18. Whole-exome sequencing revealed mutational profiles of giant cell glioblastomas.
Shi ZF; Li KK; Kwan JSH; Yang RR; Aibaidula A; Tang Q; Bao Y; Mao Y; Chen H; Ng HK
Brain Pathol; 2019 Nov; 29(6):782-792. PubMed ID: 30861589
[TBL] [Abstract] [Full Text] [Related]
19. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
AlHarbi M; Ali Mobark N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Hussain ME; Balbaid AAO; Said Marie A; AlSubaie L; AlShieban S; alTassan N; Ramkissoon SH; Abedalthagafi M
Oncologist; 2018 Dec; 23(12):1401-1406. PubMed ID: 30104292
[TBL] [Abstract] [Full Text] [Related]
20. G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
Yang CA; Huang HY; Lin CL; Chang JG
J Neurooncol; 2018 Sep; 139(3):661-670. PubMed ID: 29845423
[TBL] [Abstract] [Full Text] [Related]
[Next]
